These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1065 related articles for article (PubMed ID: 6154164)
1. Effect of lymphokine-containing sera on adenocarcinoma BW10232 and melanoma B16 in C57BL/6 mice. Moulton RG; Daniels JC J Natl Cancer Inst; 1980 Apr; 64(4):901-3. PubMed ID: 6154164 [TBL] [Abstract][Full Text] [Related]
2. [BCG-induced production of a factor inhibiting macrophage migration and growth of melanoma B16]. Gankovskaia LV; Pyl'nova TI; Sokolova EV; Koval'chuk LV Biull Eksp Biol Med; 1980 Sep; 90(9):346-8. PubMed ID: 7000202 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of growth of B16 murine malignant melanoma by exogenous interferon. Bart RS; Porzio NR; Kopf AW; Vilcek JT; Cheng EH; Farcet Y Cancer Res; 1980 Mar; 40(3):614-9. PubMed ID: 6162552 [TBL] [Abstract][Full Text] [Related]
4. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801 [TBL] [Abstract][Full Text] [Related]
5. A new mouse model of experimental melanoma for vaccine and lymphokine therapy. Shrayer DP; Bogaars H; Wolf SF; Hearing VJ; Wanebo HJ Int J Oncol; 1998 Aug; 13(2):361-74. PubMed ID: 9664134 [TBL] [Abstract][Full Text] [Related]
6. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. Pearlstein E; Ambrogio C; Karpatkin S Cancer Res; 1984 Sep; 44(9):3884-7. PubMed ID: 6744304 [TBL] [Abstract][Full Text] [Related]
7. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals. Hidvégi M; Ráso E; Tömösközi-Farkas R; Paku S; Lapis K; Szende B Anticancer Res; 1998; 18(4A):2353-8. PubMed ID: 9703878 [TBL] [Abstract][Full Text] [Related]
8. [Cytotoxic immunity indices of melanoma B16 growth in mice]. Korosteleva TA; Veresova OV Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591 [TBL] [Abstract][Full Text] [Related]
9. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin. Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455 [TBL] [Abstract][Full Text] [Related]
10. Demonstration of immunogenicity with the poorly immunogenic B16 melanoma. Celik C; Lewis DA; Goldrosen MH Cancer Res; 1983 Aug; 43(8):3507-10. PubMed ID: 6861123 [TBL] [Abstract][Full Text] [Related]
11. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials. LeGrue SJ; Hearn DR Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449 [TBL] [Abstract][Full Text] [Related]
12. [The inhibitory effect of recombinant fibronectin polypeptide CH50 on the growth of B16 melanoma]. Zhang H; Feng Z; Zhang G Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):416-8. PubMed ID: 11776614 [TBL] [Abstract][Full Text] [Related]
13. Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells. Kikuchi T; Miyazawa N; Moore MA; Crystal RG Cancer Res; 2000 Nov; 60(22):6391-5. PubMed ID: 11103803 [TBL] [Abstract][Full Text] [Related]
14. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor. Björkdahl O; Dohlsten M; Sjögren HO Cancer Gene Ther; 2000 Oct; 7(10):1365-74. PubMed ID: 11059695 [TBL] [Abstract][Full Text] [Related]
15. Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma. Pierson HF; Meadows GG Cancer Res; 1983 May; 43(5):2047-51. PubMed ID: 6831435 [TBL] [Abstract][Full Text] [Related]
16. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination]. Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746 [TBL] [Abstract][Full Text] [Related]
17. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma]. Zheng HQ; Liu DY Ai Zheng; 2003 Apr; 22(4):363-7. PubMed ID: 12703989 [TBL] [Abstract][Full Text] [Related]
18. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties. Irimura T; Gonzalez R; Nicolson GL Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906 [TBL] [Abstract][Full Text] [Related]
19. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma. Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546 [TBL] [Abstract][Full Text] [Related]
20. Immunization of mice with irradiated melanoma tumor cells transfected to secrete lymphokines and coupled with IL-2 or GM-CSF therapy. Shrayer DP; Bogaars H; Hearing VJ; Wanebo HJ J Exp Ther Oncol; 1996 Mar; 1(2):126-33. PubMed ID: 9414396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]